Bioengineering Technology Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

The bioengineering technology market size has grown rapidly in recent years. It will grow from $282.19 billion in 2023 to $320.38 billion in 2024 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing aging population, increasing prevalence of chronic diseases, bioengineering technology market growth, favorable government initiatives, growing genetic engineering strategies.

The bioengineering technology market size is expected to see rapid growth in the next few years. It will grow to $521.98 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to increased focus on cell therapies, rapid growth of synthetic biology, precision medicine advancements, increasing application in agriculture, expanded use in environmental solutions. Major trends in the forecast period include advanced gene editing techniques, convergence of technologies, advancements in precision medicine, global collaboration and partnership, synthetic biology applications.

Market Overview -
Bioengineering technology refers to the application of principles and techniques from engineering and the natural sciences to develop technologies and solutions for understanding, manipulating, and utilizing biological systems. It is used to solve problems and improve processes in the fields of medicine, biology, and healthcare.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=13609&type=smp

Rising Prevalence Of Chronic Diseases Propels Bioengineering Technology Market Growth
The increasing prevalence of chronic diseases is expected to propel the growth of the bioengineering technology market going forward. Chronic diseases are referred to as long-term health conditions characterized by their prolonged and persistent nature. Bioengineering technology is used in the management and treatment of chronic diseases due to its potential to provide innovative solutions, improve outcomes, and enhance the quality of life for patients. For instance, in January 2023, according to the National Centre for Biotechnology Information, a US-based division of the National Library of Medicine, chronic conditions are anticipated to increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. Therefore, the increasing prevalence of chronic diseases is driving the growth of the bioengineering technology market.

Competitive Landscape -
Major companies operating in the bioengineering technology market report are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Moderna Inc., Becton Dickinson (BD), Regeneron Pharmaceuticals, Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Agilent Technologies, Lonza Group Ltd., Intuitive Surgical, Illumina, Inc, Bio-Rad Laboratories, Ginkgo Bioworks, Verve Therapeutics, Inc., CRISPR Therapeutics

Bioprinting Innovations Propel Bioengineering Technology Market
Major companies operating in the bioengineering technology market are developing innovative technological products, such as Mito Plus, to advance the field of regenerative medicine. Mito Plus is an indigenous, state-of-the-art 3D bioprinter. It is the process of producing tissue or organs like natural body parts, containing living cells, using 3D printing technology. For instance, in November 2022, Avay Biosciences Pvt. Ltd., an India-based manufacturer and service provider of 3D printers, introduced Mito Plus, an innovative bioprinter designed for human tissues. It is described as one of the most advanced bioprinters in its price range, capable of printing a wide range of biomaterials and having inbuilt UV curing options. It also features HEPA filters and temperature control, allowing the printhead and the print bed to be cooled up to 4 degrees Celsius as well as heated.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/bioengineering-technology-global-market-report

Key Segments -

The bioengineering technology market covered in this report is segmented -

1) By Product: Biomedical Engineering, Genetic Engineering, Biotechnology, Tissue Engineering, Biomechanics Engineering, Biomaterial, Biomechanical Engineering, Nano-biotechnology, Bioinformatics, Other Products
2) By Technology: Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-based Assays, Fermentation
3) By Application: Health, Food And Agriculture, Natural Resources And Environment

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.